Eli Lilly and Co
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 43K
- Market Cap
- $859.4B
- Introduction
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
A Study of Chemotherapy Treatment for Patients With Ovarian Cancer
- Conditions
- Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
- Interventions
- Drug: LY573636-sodium
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2018-04-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 103
- Registration Number
- NCT00428610
- Locations
- 🇷🇺
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Moscow, Russian Federation
Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2020-11-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 73
- Registration Number
- NCT00428714
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison, Wisconsin, United States
Duloxetine Versus Placebo in Chronic Low Back Pain
- First Posted Date
- 2007-01-19
- Last Posted Date
- 2009-11-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 236
- Registration Number
- NCT00424593
- Locations
- 🇳🇱
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p, Rotterdam, Netherlands
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2009-06-10
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 342
- Registration Number
- NCT00422734
- Locations
- 🇲🇽
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., La Joya, Mexico
Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction
- Conditions
- ImpotenceErectile Dysfunction
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2007-10-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 200
- Registration Number
- NCT00422578
- Locations
- 🇫🇮
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampere, Finland
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Duloxetine hydrochlorideDrug: Placebo
- First Posted Date
- 2007-01-15
- Last Posted Date
- 2011-07-26
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 339
- Registration Number
- NCT00422162
- Locations
- 🇿🇦
For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559 or 1-317-615-4559), Mon-Fri, 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST) or speak with your personal physician, Pretoria, South Africa
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 28
- Registration Number
- NCT00420381
- Locations
- 🇺🇸
Gynecologic Oncology Group 215-854-0770, Philadelphia, Pennsylvania, United States
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
- Conditions
- Erectile DysfunctionSpinal Cord Injuries
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2007-10-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 180
- Registration Number
- NCT00421083
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Indianapolis, Indiana, United States
A Study for Patients With Diabetes Mellitus (IOPA)
- Conditions
- Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- Interventions
- Drug: Human insulin 30/70Drug: Insulin lispro low mix
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2009-06-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 117
- Registration Number
- NCT00420095
- Locations
- 🇨🇳
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hefei, China
A Study for Participants With Major Depression
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 469
- Registration Number
- NCT00420004
- Locations
- 🇷🇴
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lasi, Romania